CVS pulls Zantac, which contains ranitidine, from the shelves over possible link to cancer


CVS Pharmacy will quit selling heartburn drug Zantac and generic ranitidine products during an ongoing FDA investigation in possible cancer risks.

      



READ SOURCE

See also  These travel plays may boost your portfolio – with one major exception

LEAVE A REPLY

Please enter your comment!
Please enter your name here